Manual of percutaneous coronary interventions : a step-by-step approach /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London, United Kingdom :
Academic Press,
[2021]
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- Manual of Percutaneous Coronary Interventions
- Copyright Page
- Dedication
- Contents
- List of contributors
- PCI cases online links
- CTO PCI cases online links
- Introduction
- Reference
- A. The steps
- 1 Planning
- 1.1 Planning
- 1.2 Monitoring
- 1.3 Pharmacology
- 1.4 Access
- 1.5 Engagement
- 1.6 Angiography
- 1.7 Determine target lesion(s)
- 1.8 Wiring
- 1.9 Lesion preparation
- 1.10 Stenting
- 1.11 Access closure
- 1.12 Physiology
- 1.13 Imaging
- 1.14 Hemodynamic support
- References
- 2 Monitoring
- 2.1 Patient
- 2.2 Electrocardiogram
- 2.3. Pressure waveform
- 2.4 Oxygen saturation
- 2.5 Radiation dose-X-ray system and shield positioning
- 2.6 Contrast volume
- 2.7 Access site
- 2.8 Medication administration (anticoagulation-ACT, sedation, other medications)
- 2.9 Operator and t3 eam performance
- 2.10 Cath lab environment
- 2.11 Sterile field and equipment
- 2.12 Equipment position within the body
- 3 Medications
- 3.1 Sedatives and analgesics
- 3.1.1 Goals
- 3.1.2 How?
- 3.1.3 What can go wrong?
- 3.1.3.1 Respiratory failure-hypopnea
- 3.1.3.2 Delayed response to oral P2Y12 inhibitors which may lead to thrombotic complications
- 3.2 Vasodilators
- 3.2.1 Nitroglycerin
- 3.2.1.1 Goals
- 3.2.1.2 How?
- 3.2.1.3 What can go wrong?
- 3.2.1.3.1 Hypotension
- 3.2.1.3.2 Headache, flushing, dizziness
- 3.2.1.3.3 Tachycardia
- 3.2.2 Nicardipine
- 3.2.2.1 Goals
- 3.2.2.2 How?
- 3.2.2.3 What can go wrong?
- 3.2.2.3.1 Hypotension
- 3.2.3 Nitroprusside
- 3.2.3.1 Goals
- 3.2.3.2 How?
- 3.2.3.3 What can go wrong?
- 3.2.3.3.1 Hypotension
- 3.2.4 Verapamil
- 3.2.4.1 Goals
- 3.2.4.2 How?
- 3.2.4.3 What can go wrong?
- 3.2.4.3.1 Hypotension
- 3.2.5 Adenosine
- 3.2.5.1 Goals
- 3.2.5.2 How?
- 3.2.5.3 What can go wrong?
- 3.2.5.3.1 Heart block
- 3.2.5.3.2 Atrial fibrillation
- 3.2.5.3.3 Ventricular fibrillation
- 3.3 Contrast media
- 3.3.1 Goals
- 3.3.2 How?
- 3.3.3 What can go wrong?
- 3.3.3.1 Contrast-induced acute kidney injury
- 3.3.3.2 Allergic reactions
- 3.3.3.3 Thyroid dysfunction
- 3.4 Anticoagulants
- 3.4.1 Goals
- 3.4.2 How?
- 3.4.2.1 Unfractionated heparin
- 3.4.2.1.1 Dose
- 3.4.2.1.2 Monitoring
- 3.4.2.1.3 Reversal
- 3.4.2.2 Bivalirudin
- 3.4.2.2.1 Dose
- 3.4.2.2.2 Monitoring
- 3.4.2.2.3 Reversal
- 3.4.3 Challenges
- 3.4.3.1 ACT is low after anticoagulant administration
- 3.4.4 What can go wrong?
- 3.4.4.1 Bleeding
- 3.4.4.2 Thrombosis
- 3.4.4.3 Heparin-induced thrombocytopenia (HIT)
- 3.5 Antiplatelet agents
- 3.5.1 Dual antiplatelet therapy
- 3.5.1.1 Goals
- 3.5.1.2 How?
- 3.5.1.2.1 Medication type
- 3.5.1.2.2 Dose
- 3.5.1.2.3 Pretreatment
- 3.5.1.2.4 Switching between oral P2Y12 inhibitors
- 3.5.1.2.5 DAPT duration
- 3.5.1.3 What can go wrong?
- 3.5.1.3.1 Bleeding
- 3.5.1.3.2 Dyspnea
- 3.5.1.3.3 Allergic reactions